Esper Bionics develops prostheses and prosthetic control technologies for people with limb differences as well as assistive devices and wearable sensors for paralyzed individuals. The company aims to create a bionic ecosystem of connected devices to enhance human capabilities.

Esper Bionics

TRS Heating, Air Conditioning, & Electrical Excellence provides HVAC services including repair, maintenance, and installation of air conditioning and heating systems. The company also offers electrical services including generator maintenance.

TRS Heating, Air Conditioning, & Electrical Excellence

Bionics Institute focuses on medical device development, particularly in researching solutions for autoimmune and chronic conditions, brain diseases, chronic pain, and hearing and vision impairments.

Bionics Institute

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.

Metric
Company Name	Esper Bionics	TRS Heating, Air Conditioning, & Electrical Excellence	Bionics Institute	Ekso Bionics Holdings, Inc.
Symbol				EKSO
MSH ID	COM:ESPERBIONICS	COM:TRSHEATINGANDAIRCONDITIONING	ORG:BIONICSINSTITUTE	COM:EKSOBIONICS
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Commercial & Professional Services	Healthcare & Health Services	Healthcare
Industry	Medical Devices	HVAC Services	Medical Research	Medical - Instruments & Supplies
Country	US	US	AU	US
Stage	Venture Round
Employee Count				70
Website	esperbionics.com	trsheatingandairconditioning.com	bionicsinstitute.org	eksobionics.com
LinkedIn				eksobionics
Founders

Metric
Market Cap		19.73M
Enterprise Value
Monthly Web Traffic	2.67K
Web Traffic Growth	0.57
Valuation
Raised Capital	5M

Metric
Revenue				18.28M
Revenue (LTM)
Revenue (NTM)
Gross Profit				9.70M
EBITDA				-13.41M
Operating Income				-15.11M
Net Income				-15.20M
EPS				-1.10
Diluted EPS				-1.10
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.52
Operating Profit Margin				-0.66
EBITDA Margin				-0.73
Net Profit Margin				-0.68
Return on Equity				-0.90
Return on Assets				-0.46
Return on Capital Employed				-0.62

ESPE

COM:ESPERBIONICS

Esper Bionics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				-2.21
P/B Ratio				2.00
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				1.50
EV Multiple				-1.50

Metric
Days Sales Outstanding				126.22
Days Payables Outstanding				106.25
Days Inventory Outstanding				209.80
Operating Cycle				338.60
Cash Conversion Cycle				250.35
Asset Turnover				0.67

Metric
Operating Cash Flow				-12.05M
Free Cash Flow				-12.21M
Cash Flow to Debt				-1.26
Operating Cash Flow/Sales				-0.46
Free Cash Flow Yield				-0.37

Metric
Cash & Equivalents				8.64M
Accounts Receivable				-1.21M
Inventory				5.05M
Goodwill				431K
Debt to Capitalization				0.36
Debt to Assets				0.24
Current Ratio				2.85
Quick Ratio				2.11

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue				0.16
R&D to Revenue				0.27
SG&A to Revenue				0.67